Measuring the diaspora for virus-specific CD8+ T cells
- PMID: 11344265
- PMCID: PMC33465
- DOI: 10.1073/pnas.101132698
Measuring the diaspora for virus-specific CD8+ T cells
Abstract
The CD8(+) T cell diaspora has been analyzed after secondary challenge with an influenza A virus that replicates only in the respiratory tract. Numbers of D(b)NP(366)- and D(b)PA(224)-specific CD8(+) T cells were measured by tetramer staining at the end of the recall response, then followed sequentially in the lung, lymph nodes, spleen, blood, and other organs. The extent of clonal expansion did not reflect the sizes of the preexisting memory T cell pools. Although the high-frequency CD8(+) tetramer(+) populations in the pneumonic lung and mediastinal lymph nodes fell rapidly from peak values, the "whole mouse" virus-specific CD8(+) T cell counts decreased only 2-fold over the 4 weeks after infection, then subsided at a fairly steady rate to reach a plateau at about 2 months. The largest numbers were found throughout in the spleen, then the bone marrow. The CD8(+)D(b)NP(366)+ and CD8(+)D(b)PA(224)+ sets remained significantly enlarged for at least 4 months, declining at equivalent rates while retaining the nucleoprotein > acid polymerase immunodominance hierarchy characteristic of the earlier antigen-driven phase. Lowest levels of the CD69 "activation marker" were detected consistently on virus-specific CD8(+) T cells in the blood, then the spleen. Those in the bone marrow and liver were intermediate, and CD69(hi) T cells were very prominent in the regional lymph nodes and the nasal-associated lymphoid tissue. Any population of "resting" CD8(+) memory T cells is thus phenotypically heterogeneous, widely dispersed, and subject to broad homeostatic and local environmental effects irrespective of epitope specificity or magnitude.
Figures



Similar articles
-
A previously unrecognized H-2D(b)-restricted peptide prominent in the primary influenza A virus-specific CD8(+) T-cell response is much less apparent following secondary challenge.J Virol. 2000 Apr;74(8):3486-93. doi: 10.1128/jvi.74.8.3486-3493.2000. J Virol. 2000. PMID: 10729122 Free PMC article.
-
Antigen-specific CD8(+) T cells persist in the upper respiratory tract following influenza virus infection.J Immunol. 2001 Sep 15;167(6):3293-9. doi: 10.4049/jimmunol.167.6.3293. J Immunol. 2001. PMID: 11544317
-
Concurrent naive and memory CD8(+) T cell responses to an influenza A virus.J Immunol. 2001 Sep 1;167(5):2753-8. doi: 10.4049/jimmunol.167.5.2753. J Immunol. 2001. PMID: 11509619
-
Hierarchies in cytokine expression profiles for acute and resolving influenza virus-specific CD8+ T cell responses: correlation of cytokine profile and TCR avidity.J Immunol. 2004 May 1;172(9):5553-60. doi: 10.4049/jimmunol.172.9.5553. J Immunol. 2004. PMID: 15100298
-
Establishment and recall of CD8+ T-cell memory in a model of localized transient infection.Immunol Rev. 2006 Jun;211:133-45. doi: 10.1111/j.0105-2896.2006.00386.x. Immunol Rev. 2006. PMID: 16824123 Review.
Cited by
-
Defining the molecular blueprint that drives CD8(+) T cell differentiation in response to infection.Front Immunol. 2012 Dec 19;3:371. doi: 10.3389/fimmu.2012.00371. eCollection 2012. Front Immunol. 2012. PMID: 23267358 Free PMC article.
-
An investigation of the impact of the location and timing of antigen-specific T cell division on airways inflammation.Clin Exp Immunol. 2009 Jan;155(1):107-16. doi: 10.1111/j.1365-2249.2008.03800.x. Clin Exp Immunol. 2009. PMID: 19076834 Free PMC article.
-
Silencing of T lymphocytes by antigen-driven programmed death in recombinant adeno-associated virus vector-mediated gene therapy.Blood. 2009 Jan 15;113(3):538-45. doi: 10.1182/blood-2008-01-131375. Epub 2008 Jun 19. Blood. 2009. PMID: 18566327 Free PMC article.
-
Peripheral regulation of T cells by dendritic cells during infection.Immunol Res. 2014 Aug;59(1-3):66-72. doi: 10.1007/s12026-014-8530-3. Immunol Res. 2014. PMID: 24838143 Review.
-
Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment.J Virol. 2003 Apr;77(8):4911-27. doi: 10.1128/jvi.77.8.4911-4927.2003. J Virol. 2003. PMID: 12663797 Free PMC article.
References
-
- Altman J D, Moss P A H, Goulder P J R, Barouch D H, McHeyzer-Williams M G, Bell J I, McMichael A J, Davis M M. Science. 1996;274:94–96. - PubMed
-
- Murali-Krishna K, Altman J D, Suresh M, Sourdive D J, Zajac A J, Miller J D, Slansky J, Ahmed R. Immunity. 1998;8:177–187. - PubMed
-
- Flynn K J, Belz G T, Altman J D, Ahmed R, Woodland D L, Doherty P C. Immunity. 1998;8:683–691. - PubMed
-
- Doherty P C, Christensen J P. Annu Rev Immunol. 2000;18:561–592. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous